Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
 Disease Category: Breast Cancer
Location: United States, CA

Trial Information

Efficacy and Tolerability of Nanoparticle Albumin Bound Paclitaxel (Abraxane) in Patients 65 and Older with Metastatic Breast Cancer

You have been asked to participate in this research study because you have breast cancer that has spread to other parts of your body and you are going to receive treatment with the drug, nab-paclitaxel.  The purpose of this study is to evaluate the tolerability and effectiveness of this treatment.  Your treatment on this study is expected to last as long as your disease does not worsen and you do not have unmanageable side effects.  After your treatment on this study is over, your medical condition will continue to be followed for 30 days or until all significant side effects have resolved to levels at the start of study.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.